- Home
- OSUR vs CHPT Comparison
OSUR vs CHPT Comparison
Compare OSUR & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- CHPT
- Stock Information
- Founded
- OSUR 2000
- CHPT 2007
- Country
- OSUR United States
- CHPT United States
- Employees
- OSUR N/A
- CHPT N/A
- Industry
- OSUR Medical/Dental Instruments
- CHPT Industrial Specialties
- Sector
- OSUR Health Care
- CHPT Consumer Discretionary
- Exchange
- OSUR Nasdaq
- CHPT Nasdaq
- Market Cap
- OSUR 231.1M
- CHPT 256.9M
- IPO Year
- OSUR 1986
- CHPT N/A
- Fundamental
- Price
- OSUR $2.44
- CHPT $9.58
- Analyst Decision
- OSUR Hold
- CHPT Hold
- Analyst Count
- OSUR 1
- CHPT 11
- Target Price
- OSUR $3.00
- CHPT $18.40
- AVG Volume (30 Days)
- OSUR 538.2K
- CHPT 364.3K
- Earning Date
- OSUR 11-05-2025
- CHPT 12-03-2025
- Dividend Yield
- OSUR N/A
- CHPT N/A
- EPS Growth
- OSUR N/A
- CHPT N/A
- EPS
- OSUR N/A
- CHPT N/A
- Revenue
- OSUR $125,703,000.00
- CHPT $397,731,000.00
- Revenue This Year
- OSUR N/A
- CHPT N/A
- Revenue Next Year
- OSUR $4.32
- CHPT $12.67
- P/E Ratio
- OSUR N/A
- CHPT N/A
- Revenue Growth
- OSUR N/A
- CHPT N/A
- 52 Week Low
- OSUR $2.30
- CHPT $8.55
- 52 Week High
- OSUR $4.37
- CHPT $30.00
- Technical
- Relative Strength Index (RSI)
- OSUR 30.66
- CHPT 37.57
- Support Level
- OSUR $2.30
- CHPT $9.25
- Resistance Level
- OSUR $2.51
- CHPT $10.09
- Average True Range (ATR)
- OSUR 0.11
- CHPT 0.46
- MACD
- OSUR -0.03
- CHPT -0.12
- Stochastic Oscillator
- OSUR 20.00
- CHPT 14.52
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.